W. Tony Parks, MD
Associate Professor of Pathology

Dr. Parks Dr. Parks is Director of Perinatal Pathology at Magee-Womens Hospital of UPMC.
Office Location:
Magee-Womens Hospital of UPMC
Department of Pathology
Room 4436
300 Halket Street
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-641-3708
Division Telephone: 412-641-4641
Email: parkswa@upmc.edu


  • BS - University of Michigan, 1983
  • MD - Washington University School of Medicine, 1988

Clinical Expertise

Dr. Parks' clinical interest is in perinatal pathology, including fetal autopsy and placental pathology. Dr. Parks is the Director of Perinatal Pathology at Magee-Womens Hospital, where he currently examines the majority of the perinatal cases, approximately 4500 placentas and 100 autopsies per year.

Research Interests

Dr. Parks' research interests include trophoblast function and mechanisms of stillbirth. Dr. Parks is involved in multiple research collaborations with investigators from the Magee-Womens Research Institute, the University of Pittsburgh School of Public Health, the University of Pittsburgh School of Nursing and the Department of Obstetrics-Gynecology at Magee-Womens Hospital.

Selected Publications

View Dr. Parks' publications on PubMed

Cajaiba MM, Parks WT, Fuhrer K, Randhawa PS. Evaluation of human polyomavirus BK as a potential cause of villitis of unknown etiology and spontaneous abortion. J Med Virol 2011; 83(6):1031-3.

Castro EC, Parks WT, Galambos C. Neither normal nor diseased placentas contain lymphatic vessels. Placenta 2011; 32(4):310-6.

Founds SA, Fallert-Junecko B, Reinhart TA, Conley YP, Parks WT. LAIR2 localizes specifically to sites of extravillous trophoblast invasion. Placenta 2010; 31(10):880-5.

Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, Sadovsky Y. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 2010; 31(9):781-4.

Hoffner L, Parks WT, Swerdlow SH, Carson JC, Surti U. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies. J Reprod Med 2010; 55(5-6):219-28.